Abiopharma

🔍 PELIZZA MARK S (Executive)

Company: enCore Energy Corp. (EU)

Report Date: 2026-06-11

Detailed Transactions and Holdings:

• Acquired 99,182 shares of Common Stock at $1.37 per share (Direct)
  Date: 2026-06-11 | Code: P | equity_swap_involved: false | shares_owned_after: 237,515.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 723 shares of Common Stock at $1.39 per share (Direct)
  Date: 2026-06-12 | Code: P | equity_swap_involved: false | shares_owned_after: 238,238.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-11 | Code: H | nature_of_ownership: By Family Trust | shares_owned_after: 443,332.00

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.36 to $1.39, inclusive. The reporting person undertakes to provide to enCore Energy Corp., any security holder of enCore Energy Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this form
• F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.40, inclusive. The reporting person undertakes to provide to enCore Energy Corp., any security holder of enCore Energy Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this form
• REMARKS: Exhibit List: Exhibit 24 Power of Attorney